OPPI’s Matai On Winds Of Policy Change In India, Quality Oversight

Incoming director general of the Organisation of Pharmaceutical Producers of India, Anil Matai, talks to Scrip about the evolving policy and regulatory landscape in India in areas such as R&D and quality. Stricter adherence to ethical marketing practices and transparency in interactions between pharma and physicians could be key focus areas in the coming year, he adds.